C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Senior Manager, Drug Substance Manufacturing

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$173.4k - $204k

About the Job

Requirements

  • The role requires strong experience in small molecule active pharmaceutical ingredient manufacturing, late-stage chemistry, manufacturing, and controls development, good manufacturing practice operations, and cross-functional collaboration.
  • A Master's degree is associated with 8 or more years of relevant experience, or a Ph.D. with 5 or more years of relevant experience; the posting marks this education and experience section as preferred while stating the experience as required.
  • Candidates should have strong experience in small molecule active pharmaceutical ingredient manufacturing, preferably supporting late-phase clinical, validation, or commercial programs.
  • Candidates should have demonstrated experience working with contract manufacturing organizations and managing external manufacturing campaigns.
  • Candidates should have experience managing non-good-manufacturing-practice manufacture of regulatory starting materials, advanced intermediates, or key raw materials used in small molecule active pharmaceutical ingredient manufacturing.
  • Candidates should be familiar with starting material justification, supplier qualification, impurity control, traceability, and change control in late-phase or commercial active pharmaceutical ingredient programs.
  • Candidates should have a solid understanding of current good manufacturing practice requirements, ICH Q7, ICH Q11, process validation, and regulatory expectations for active pharmaceutical ingredient manufacturing.
  • Candidates should have experience with process transfer, scale-up, process performance qualification preparation, deviation investigations, corrective and preventive actions, and change controls.
  • Candidates should have a strong technical understanding of synthetic organic chemistry, impurity control, process parameters, in-process controls, and manufacturing documentation.
  • Candidates should have excellent project management, technical writing, and cross-functional collaboration skills.
  • Applicants must be currently authorized to work in the United States on a full-time basis.

Responsibilities

  • Lead and manage external good-manufacturing-practice drug substance manufacturing activities for late-phase small molecule active pharmaceutical ingredient programs.
  • Oversee manufacture and supply of regulatory starting materials and key intermediates under non-good-manufacturing-practice conditions, as applicable, to support late-phase active pharmaceutical ingredient manufacturing programs.
  • Manage external partners involved in non-good-manufacturing-practice starting material manufacture, including review of manufacturing plans, process descriptions, batch documentation, quality expectations, timelines, and supply readiness.
  • Partner with Process Chemistry, Quality, Regulatory, and Supply Chain teams to ensure appropriate control, documentation, qualification, and change management for starting materials used in good-manufacturing-practice active pharmaceutical ingredient manufacture.
  • Assess risks associated with starting material sourcing and manufacture, including supplier reliability, process consistency, impurity profile, traceability, and potential impact on downstream good-manufacturing-practice active pharmaceutical ingredient manufacturing.
  • Support supplier qualification, technical assessments, and lifecycle management for starting materials and key raw materials manufactured under non-good-manufacturing-practice conditions.
  • Oversee technology transfer, scale-up, process optimization, engineering batches, process performance qualification readiness, and commercial launch preparation.
  • Serve as the primary technical and operational interface with contract manufacturing organizations for active pharmaceutical ingredient manufacturing campaigns.
  • Review and approve batch records, campaign protocols, manufacturing instructions, process validation protocols, and manufacturing reports.
  • Support process validation strategy, including process performance qualification planning, continued process verification, and process performance monitoring.
  • Lead or support deviation investigations, out-of-specification and out-of-trend assessments, root cause analysis, corrective and preventive action development, and manufacturing risk assessments.
  • Ensure manufacturing activities comply with current good manufacturing practice, ICH Q7, ICH Q11, regulatory commitments, and internal quality requirements.
  • Partner with Process Chemistry and Analytical teams to ensure robust process understanding, impurity control strategy, and process control strategy.
  • Support preparation and review of chemistry, manufacturing, and controls regulatory sections for investigational new drug applications, new drug applications, marketing authorization applications, Type II variations, supplements, and health authority responses.
  • Review and assess proposed changes related to raw materials, starting materials, suppliers, process parameters, equipment, manufacturing sites, and analytical methods.
  • Manage contract manufacturing organization performance, manufacturing timelines, issue escalation, and cross-functional alignment on project deliverables.
  • Support supplier qualification, raw material strategy, manufacturing readiness, and lifecycle management activities.
  • Contribute to continuous improvement initiatives to enhance process robustness, manufacturing efficiency, and supply reliability.

Desired Qualifications

  • Direct experience supporting new drug application, marketing authorization application, or commercial launch readiness for small molecule active pharmaceutical ingredients.
  • Experience with post-approval changes, process validation lifecycle, continued process verification, and regulatory inspection support.
  • Familiarity with quality risk management principles and impurity control strategies, including genotoxic impurities and nitrosamine risk assessments.
  • Experience supporting supplier qualification, raw material change assessments, and contract manufacturing organization audits.
  • Prior experience in outsourced development and manufacturing models.
  • Preferred education is a Master's or Ph.D. degree in Chemistry, Chemical Engineering, Pharmaceutical Sciences, or a related scientific discipline.
  • Experience contributing to chemistry, manufacturing, and controls regulatory submissions and health authority responses.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs